Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes
- PMID: 26069717
- PMCID: PMC4458497
- DOI: 10.4239/wjd.v6.i5.679
Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes
Abstract
Macro and microvascular disease are the main cause of morbi-mortality in type 1 diabetes (T1DM). Although there is a clear association between endothelial dysfunction and atherosclerosis in type 2 diabetes, a cause-effect relationship is less clear in T1DM. Although endothelial dysfunction (ED) precedes atherosclerosis, it is not clear weather, in recent onset T1DM, it may progress to clinical macrovascular disease. Moreover, endothelial dysfunction may either be reversed spontaneously or in response to intensive glycemic control, long-term exercise training and use of statins. Acute, long-term and post-prandial hyperglycemia as well as duration of diabetes and microalbuminuria are all conditions associated with ED in T1DM. The pathogenesis of endothelial dysfunction is closely related to oxidative-stress. NAD(P)H oxidase over activity induces excessive superoxide production inside the mitochondrial oxidative chain of endothelial cells, thus reducing nitric oxide bioavailability and resulting in peroxynitrite formation, a potent oxidant agent. Moreover, oxidative stress also uncouples endothelial nitric oxide synthase, which becomes dysfunctional, inducing formation of superoxide. Other important mechanisms are the activation of both the polyol and protein kinase C pathways as well as the presence of advanced glycation end-products. Future studies are needed to evaluate the potential clinical applicability of endothelial dysfunction as a marker for early vascular complications in T1DM.
Keywords: Cardiovascular disease; Endothelial dysfunction; Type 1 diabetes.
Similar articles
-
Reversibility of endothelial dysfunction in diabetes: role of polyphenols.Br J Nutr. 2016 Jul;116(2):223-46. doi: 10.1017/S0007114516001884. Epub 2016 Jun 6. Br J Nutr. 2016. PMID: 27264638 Review.
-
Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.Curr Pharm Des. 2013;19(32):5695-703. doi: 10.2174/1381612811319320005. Curr Pharm Des. 2013. PMID: 23448484 Review.
-
[Endothelial dysfunction in type 1 diabetes].Arq Bras Endocrinol Metabol. 2008 Mar;52(2):416-26. doi: 10.1590/s0004-27302008000200030. Arq Bras Endocrinol Metabol. 2008. PMID: 18438553 Review. Portuguese.
-
Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.Eur J Pharmacol. 2005 Mar 21;511(1):53-64. doi: 10.1016/j.ejphar.2005.01.014. Eur J Pharmacol. 2005. PMID: 15777779
-
Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.Drugs. 2005;65(1):31-74. doi: 10.2165/00003495-200565010-00003. Drugs. 2005. PMID: 15610050 Review.
Cited by
-
Exercise training and vascular heterogeneity in db/db mice: evidence for regional- and duration-dependent effects.Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr;397(4):2421-2436. doi: 10.1007/s00210-023-02775-0. Epub 2023 Oct 16. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37843589
-
Endothelial Dysfunction in Cardiorenal Conditions: Implications of Endothelial Glucocorticoid Receptor-Wnt Signaling.Int J Mol Sci. 2023 Sep 19;24(18):14261. doi: 10.3390/ijms241814261. Int J Mol Sci. 2023. PMID: 37762564 Free PMC article. Review.
-
Relationship between the Soluble F11 Receptor and Annexin A5 in African Americans Patients with Type-2 Diabetes Mellitus.Biomedicines. 2022 Jul 28;10(8):1818. doi: 10.3390/biomedicines10081818. Biomedicines. 2022. PMID: 36009365 Free PMC article.
-
Cardiovascular Risk Stratification in Diabetic Retinopathy via Atherosclerotic Pathway in COVID-19/Non-COVID-19 Frameworks Using Artificial Intelligence Paradigm: A Narrative Review.Diagnostics (Basel). 2022 May 14;12(5):1234. doi: 10.3390/diagnostics12051234. Diagnostics (Basel). 2022. PMID: 35626389 Free PMC article. Review.
-
Protective effects of physical activity against health risks associated with type 1 diabetes: "Health benefits outweigh the risks".World J Diabetes. 2022 Mar 15;13(3):161-184. doi: 10.4239/wjd.v13.i3.161. World J Diabetes. 2022. PMID: 35432757 Free PMC article. Review.
References
-
- The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977–986. - PubMed
-
- Giannini C, Mohn A, Chiarelli F, Kelnar CJ. Macrovascular angiopathy in children and adolescents with type 1 diabetes. Diabetes Metab Res Rev. 2011;27:436–460. - PubMed
-
- Järvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, Lehtimäki T, Rönnemaa T, Viikari J, Raitakari OT. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation. 2004;109:1750–1755. - PubMed
-
- Cé GV, Rohde LE, da Silva AM, Puñales MK, de Castro AC, Bertoluci MC. Endothelial dysfunction is related to poor glycemic control in adolescents with type 1 diabetes under 5 years of disease: evidence of metabolic memory. J Clin Endocrinol Metab. 2011;96:1493–1499. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources